Exosomes as Drug Carriers for Cancer Therapy

Mol Pharm. 2019 May 6;16(5):1789-1798. doi: 10.1021/acs.molpharmaceut.9b00104. Epub 2019 Apr 16.

Abstract

Exosomes, biological extracellular vesicles, have recently begun to find use in targeted drug delivery in solid tumor research. Ranging from 30-120 nm in size, exosomes are secreted from cells and isolated from bodily fluids. Exosomes provide a unique material platform due to their characteristics, including physical properties such as stability, biocompatibility, permeability, low toxicity, and low immunogenicity-all critical to the success of any nanoparticle drug delivery system. In addition to traditional chemotherapeutics, natural products and RNA have been encapsulated for the treatment of breast, pancreatic, lung, prostate cancers, and glioblastoma. This review discusses current research on exosomes for drug delivery to solid tumors.

Keywords: drug delivery; exosomes; nanoparticles; solid tumor.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Biological Products
  • Drug Carriers*
  • Drug Delivery Systems / methods*
  • Exosomes*
  • Humans
  • Mice
  • Milk / cytology
  • Nanoparticles / adverse effects
  • Neoplasms / drug therapy*
  • Xenograft Model Antitumor Assays / methods
  • Zebrafish

Substances

  • Biological Products
  • Drug Carriers